
export const education = [
  {
    clientName: "Capso(88763249)",
    reportPeriod: "R&D Report for financial period ending 30 June 2018",
    companyContract: "Company contact: Andrew Johnson, Project Manager",
    claimDetails: [
      {
        status: "Claim period",
        details:
          "Capso Therapeutics (the company) has compiled this document to support its claim for R& relief for accounting period 29 June 2017 to 30 June 2018.",
      },
      {
        status: "Scheme eligibility",
        details:
          "Capso Therapeutics had two staff. Turnover to 30 June 2018 was £84,400 and total balance sheet assets were £40,047. The company was not part of a group and had no significant hareholders or shares in other companies. Ansai Limited. is therefore considered to be an SME for the purposes of R&D tax relief.",
      },
      {
        status: "Technical objectives",
        details:
          " Working in the areas of computer science, software development, and web application development, Capso Therapeutics assessed its technical projects against the guidance of CIRD 81900 Paragraph 9a-d. The extent of its activities are summarised in the chart below.",
        claimsNumber: "Definitions of CIRD81900 Para 9a-d",
      },
    ],
    claimsBullet: [
      
     "9a: Extending overall knowledge or capability in a field of technology.",
      "9b: Wrapping new technical knowledge or capability within a product, process, device, material or s",
      
    ],
  },

];




